Finance

Beta
Lists
HRTX:NASDAQ
Heron Therapeutics Inc
$0.43
-11.60%
(-0.056) 1D
$0.43
+0.73% (+0.0031)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HRTX...
Open
$0.48
High
$0.48
Low
$0.42
Mkt. cap
81.49M
Avg. vol.
3.46M
Volume
4.39M
52-wk high
$2.30
52-wk low
$0.42
EPS
-$0.18
Beta
1.58
Shares outstanding
189.28M
No. of employees
128
Open
$0.48
High
$0.48
Low
$0.42
Mkt. cap
81.49M
Avg. vol.
3.46M
Volume
4.39M
52-wk high
$2.30
52-wk low
$0.42
EPS
-$0.18
Beta
1.58
Shares outstanding
189.28M
No. of employees
128
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to HRTX in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for HRTX in the last 3 months.
Highest
Current $0.43
$2.00 (+367.95%)
Average
$2.00 (+367.95%)
Lowest
$2.00 (+367.95%)
News stories
From sources across the web
About Heron Therapeutics Inc
CEO-
Employees128
Founded1983
HeadquartersSan Diego, California, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
37.20M
38.21M
40.59M
34.71M
Cost of goods sold
12.79M
15.38M
14.86M
13.02M
Cost of revenue
12.79M
15.38M
14.86M
13.02M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.05M
26.92M
25.68M
26.45M
Operating expense
26.05M
26.92M
25.68M
26.45M
Total operating expenses
38.84M
42.31M
40.55M
39.48M
Operating income
-1.64M
-4.09M
38.00K
-4.76M
Other non operating income
756.00K
837.00K
-821.00K
-146.00K
EBT including unusual items
-2.38M
-17.50M
-2.95M
-8.11M
EBT excluding unusual items
-2.38M
-6.16M
-2.54M
-8.11M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.38M
-17.50M
-2.95M
-8.11M
Net profit margin
-6.40%
-45.78%
-7.28%
-23.37%
Earnings per share
-0.02
-0.04
-0.02
-0.04
Interest and investment income
-
-
1.95M
-
Interest expense
-1.50M
-2.90M
-3.70M
-3.20M
Net interest expenses
-1.50M
-2.90M
-1.76M
-3.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.03M
-3.48M
575.00K
-4.24M
Gain or loss from assets sale
129.00K
-95.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more